COMMUNIQUÉS West-GlobeNewswire

Crinetics Pharmaceuticals Appoints Marc Wilson as Chief Financial Officer
04/01/2018
SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced the appointment of Marc [...]
AXIM Biotech Attends Biotech Showcase Conference in San Francisco
04/01/2018
NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief [...]
Predictive Technology Group Appoints Dr. Hugh S. Taylor, M.D. to the Predictive Technology Group's Scientific Advisory Board
04/01/2018
SALT LAKE CITY, Utah, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED) announces that Dr. Hugh S. Taylor, M.D., joined the Predictive Technology Group’s Scientific Advisory Board. [...]
Immunomedics to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
MORRIS PLAINS, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that Michael Pehl, President and Chief Executive Officer, will present an [...]
Ultragenyx to Present at J.P. Morgan Healthcare Conference
04/01/2018
NOVATO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
Auris Medical Provides Update on AM-111 Development Program
04/01/2018
Further analyses from HEALOS Phase 3 clinical trial support AM-111's otoprotective effects in patients with profound acute hearing loss Clinically and statistically significant improvement in hearing coupled with [...]
Cascadian Therapeutics Announces 2018 Outlook and Recent Progress
04/01/2018
SEATTLE, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced an overview of recent progress for tucatinib, an investigational oral [...]
International Endeavors Excited About California Marijuana Legalization
04/01/2018
TEMECULA, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE — International Endeavors Corp (OTC:IDVV) is pleased to announce the following: The arrival of 2018 in California brought with it broad legalization of [...]
EyeGate Promotes Sarah Romano to Chief Financial Officer
04/01/2018
WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two platform technologies for [...]
American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In California
04/01/2018
DENVER, CO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis [...]
PTS Diagnostics Announces New Retail Point-of-Care Software
04/01/2018
PTS Connect ProLink ® platform expands connectivity and informatics offerings INDIANAPOLIS, Jan. 04, 2018 (GLOBE NEWSWIRE) -- PTS Diagnostics, a U.S.-based manufacturer of point-of-care biometric testing devices, today [...]
Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum
04/01/2018
Pittsburgh, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]
GTX Corp and Veristride Presenting Biometric Insoles at CES 2018
04/01/2018
LOS ANGELES, Jan. 04, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced today that [...]
Allscripts to release fourth-quarter and full-year 2017 financial results February 15
04/01/2018
CHICAGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq: MDRX ) will report its financial results for the three months and full year ended December 31, 2017, after the close of stock [...]
Catalyst Biosciences Initiates Phase 2/3 Trial of Marzeptacog Alfa (activated) for Prophylaxis in Hemophilia A or B with Inhibitors
04/01/2018
Currently Enrolling Individuals with Hemophilia A or B with Inhibitors Interim Data Expected During the First Half of 2018 SOUTH SAN FRANCISCO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. ( [...]
Foamix Announces Positive Results from Phase 3 Open-Label Safety Extension Evaluating FMX-101 Topical Minocycline Foam for Treatment up to 1 Year
04/01/2018
Long Term Data on FMX-101 in Moderate-to-Severe Acne to be Presented at Winter Clinical Dermatology Conference (January 12 th -17 th ) REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Foamix [...]
Celtaxsys Secures Private Financing to Advance Acebilustat Phase 3 Cystic Fibrosis (CF) Program Preparatory Activities
04/01/2018
ATLANTA, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for rare inflammatory diseases, today announced the successful completion of a [...]
aTyr Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Cellectar Biosciences to Participate at Biotech Showcase 2018
04/01/2018
MADISON, Wis., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]

Pages